Deep-Learning Model Based on Chest X-Ray Helps Predict MACE
By Elana Gotkine HealthDay Reporter
TUESDAY, March 26, 2024 -- A deep-learning model based on a chest radiograph (CXR) for cardiovascular disease (CVD) risk (CXR CVD-Risk) predicts major adverse cardiovascular events (MACE) beyond the clinical standard, according to a study published online March 26 in the Annals of Internal Medicine.
Jakob Weiss, M.D., from Massachusetts General Hospital and Harvard Medical School in Boston, and colleagues developed and tested CXR CVD-Risk, which estimates 10-year risk for MACE from routine CXR, and compared the performance to that of the traditional atherosclerotic CVD (ASCVD) risk score. The CXR CVD-Risk model was developed using data from a cancer screening trial and was externally validated in 8,869 outpatients with unknown ASCVD risk and 2,132 outpatients with known ASCVD risk.
The researchers found that after adjustment for risk factors, the 10-year risk for MACE was higher for those with a risk of 7.5 percent or higher as predicted by CXR CVD-Risk among 8,869 outpatients with unknown ASCVD risk (adjusted hazard ratio, 1.73). CXR CVD-Risk predicted MACE beyond the traditional ASCVD risk score in the additional 2,132 outpatients with known ASCVD risk (adjusted hazard ratio, 1.88).
"Opportunistic screening of CXRs may help identify individuals at high risk for cardiovascular disease, prompting risk factor assessment and targeted prevention," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...
DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD
WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...
Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease
TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.